Discontinued — last reported Q1 '16

Non-Current Assets

Investments - Amortized Cost Basis

Humana Investments - Amortized Cost Basis increased by 9.2% to $18.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.3%, from $19.43B to $18.59B. Over 3 years (FY 2022 to FY 2025), Investments - Amortized Cost Basis shows relatively stable performance with a 2.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ2 2015
Last reportedQ1 2016
Metric ID: investments_amortized_cost

Historical Data

13 periods
 Q4 '22Q1 '23Q2 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$15.95B$16.75B$17.23B$18.30B$18.49B$19.27B$20.28B$20.02B$19.43B$19.11B$18.04B$17.02B$18.59B
QoQ Change+5.0%+2.9%+6.2%+1.0%+4.2%+5.3%-1.3%-3.0%-1.6%-5.6%-5.7%+9.2%
YoY Change+14.8%+10.4%+11.8%+9.4%+5.1%-0.8%-11.0%-15.0%-4.3%
Range$15.95B$20.28B
CAGR+5.2%
Avg YoY Growth+2.3%
Median YoY Growth+5.1%

Investments - Amortized Cost Basis at Other Companies

Frequently Asked Questions

What is Humana's investments - amortized cost basis?
Humana (HUM) reported investments - amortized cost basis of $18.59B in Q1 2026.
How has Humana's investments - amortized cost basis changed year-over-year?
Humana's investments - amortized cost basis decreased by 4.3% year-over-year, from $19.43B to $18.59B.
What is the long-term trend for Humana's investments - amortized cost basis?
Over 3 years (2022 to 2025), Humana's investments - amortized cost basis has grown at a 2.2% compound annual growth rate (CAGR), from $15.95B to $17.02B.